CDH2 and cancer: We verified HA‐TOMM20 overexpression in the tumors using immunoblots from five different tumors in each group (Fig. S5) and found that the driver of cancer invasiveness N‐cadherin, mitochondrial metabolic drivers TIGAR and monocarboxylate transporter (MCT1), antiapoptotic BCL‐2, and proapoptotic BAD were upregulated.